bioTheranostics’ CancerTYPE ID Molecular Test Gets Positive Coverage Decision, In-Network Provider Status from Tufts Health Plan
The company is working with payors nationwide to make this test available to clinicians and cancer patients.
Read More
Search Results for: lung cancer
Heartland Joint Venture Lab Group to Use Oncimmune Blood Test for Early Detection of Lung Cancer
Mid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read MoreUpcoming: CHI’s Clinical Genomics for Cancer Diagnostics Conference
The meeting will be a forum to learn more about new diagnostic tools and techniques. Hotspot testing will be compared to comprehensive genome profiling, emerging technologies will be explored, including molecular test development.
Read More
PRODUCT NEWS: AUGUST 2013
From a cart to store supplies—to lab automation, we have you covered.
Read More
Moffitt Researchers ID Gene Variations in Lung Cancer Patients That May Help Predict an Individual’s Treatment Response
Four gene variants found in non-small cell lung cancer patients indicate an increased risk of death.
Read More